Quantcast

Latest Phenols Stories

2014-10-21 08:33:43

Company's new identity to reflect its enhanced focus in chronic diseases of addiction RICHMOND, Va., Oct. 21, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) today announced its UK-based parent company, Reckitt Benckiser Group plc (RB), expects the proposed demerger of the RBP business to complete in 2014. Reckitt Benckiser originally announced plans to demerge the RBP business in late July 2014, and the operational and financial separations, appointment of the new...

2014-10-16 08:31:24

Additional Capital Enable Company to Achieve Additional Milestones in its Business Plan NEW YORK, Oct. 16, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today the issuance of approximately 10.1 million of its shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with private placements that closed in May and June 2014. The warrants...

2014-10-10 12:24:40

RALEIGH, N.C., Oct. 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that J. Chris Prue, RPh, MBA has joined BDSI as Vice President of Regulatory Affairs and Quality Assurance. Mr. Prue brings more than 30 years of pharmaceutical industry experience in regulatory affairs and quality assurance to BDSI. He has held positions of increasing responsibility at The Upjohn Company, Glaxo Inc., GlaxoWellcome and Purdue Pharma LP. Recently...

2014-10-10 12:21:11

DUBLIN, Oct. 10, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese 4,4-Biphenol Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global and Chinese 4,4-Biphenol Industry Report is a professional and in-depth study on the current state of the global 4,4-Biphenol industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions,...

2014-10-09 08:28:41

Butrans® is now available for prescribing in five dosage strengths STAMFORD, Conn., Oct. 9, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced the U.S. commercial launch of the new 7.5 mcg/hour dosage strength of Butrans(®) (buprenorphine) Transdermal System CIII. Five strengths of Butrans are now available: 5 mcg/hour, 7.5 mcg/hour, 10 mcg/hour, 15 mcg/hour and 20 mcg/hour. http://photos.prnewswire.com/prnvar/20100921/NY67262 Butrans is the first transdermal system that delivers seven days...

2014-10-08 08:26:47

RIDGEFIELD, Conn., Oct. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that Striverdi® Respimat® (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States. STRIVERDI RESPIMAT is a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. STRIVERDI RESPIMAT is not indicated to treat asthma...

2014-10-06 12:29:49

New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct. 6, 2014 /PRNewswire-USNewswire/ -- Today the National Safety Council released a white paper, Evidence for the efficacy of pain medications, compiling research showing the combination of over-the-counter pain medications ibuprofen and acetaminophen are more effective at treating acute pain than opioid painkillers. As patients find that they are unable to refill their hydrocodone...

2014-10-06 08:27:55

REDWOOD CITY, Calif., Oct. 6, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that a new data analysis from previously reported phase 3 studies evaluating the sufentanil sublingual tablet system (SSTS) for the treatment of moderate-to-severe acute pain will be presented at the International...

2014-10-01 16:26:55

Medical, Development and Legal Leadership Named RADNOR, Pa., Oct. 1, 2014 /PRNewswire/ -- Zynerba Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to the development of innovative transdermal cannabinoid treatments, today named three seasoned pharmaceutical executives to its management team. Donna Gutterman, PharmD, is a consultant who will serve in the role of vice president, medical affairs; Carol O'Neill will serve as vice president, development; and Suzanne...

2014-10-01 16:26:53

First and Only Transdermal Cannabinoid Therapeutic Company Developing Two Pre-Clinical Assets RADNOR, Pa., Oct. 1, 2014 /PRNewswire/ -- Zynerba Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to the development of innovative transdermal cannabinoid treatments, today named two leading industry veterans with track records of success in patch and gel transdermal delivery to lead the company. Armando Anido will serve as chairman of the board and chief executive...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related